Ground Swell Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Ground Swell Capital’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4K	Buy	+800	New	+$4.59K	0.01%	1631

Other funds holding FOMX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ground Swell Capital's FOMX Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2014: 800 shares worth $4K. The stake represents 0.01% of the portfolio and ranks #1631 among its holdings.

19 funds tracked by Wall St. Rank hold FOMX as of Q3 2014.

Ground Swell Capital held 800 shares of Foamix Pharmaceuticals Ltd. Ordinary Shares worth $4K as of Q3 2014.
Foamix Pharmaceuticals Ltd. Ordinary Shares was a new Ground Swell Capital position in Q3 2014.
Foamix Pharmaceuticals Ltd. Ordinary Shares made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1631 holding.
19 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.